Cambrian Biopharma Investor
Cambrian is a distributed development company building therapeutics to lengthen health span.
Technology:
Cell_Therapies, Geroscience
Industry:
Biopharma, Biotechnology, Life Science
Headquarters:
New York, New York, United States
Founded Date:
2019-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investor Type:
For Profit
Investment Stage:
Early Stage Venture
Number Of Exits:
2
Investors Number:
16
Total Funding:
160000000
Last Funding Date:
2021-10-26
Last Funding Type:
Series C
Register and Claim Ownership